{'fraction_non_alphanumeric': 0.03980891719745223, 'fraction_numerical': 0.007961783439490446, 'mean_word_length': 6.4, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Clinical risk scores and blood biomarkers as predictors of long‐term outcome in patients with community‐acquired pneumonia: a 6‐year prospective follow‐up study

Prediction of long‐term outcomes in patients with community‐acquired pneumonia (CAP) is incompletely understood. We investigated the value of clinical risk scores [pneumonia severity index (PSI) and CURB‐65] (Confusion, Urea, Respiratory rate, Blood Pressure, Age >65 years) and blood biomarkers of different physiopathological pathways in predicting long‐term survival in a well‐characterized cohort of patients with CAP enrolled in an antibiotic stewardship trial.